Lexicon Pharma (LXRX) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.27 -4.22%
Revenue Growth %: -86.1%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: -86.1%
Financial Fact:
Total revenues: 27.72M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.37 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- JPMorgan Upgrades Wolters Kluwer NV (WKL:NA) (WTKWY) to Overweight
- HSBC Starts Syrma SGS Technology (SYRMA:IN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
